Company news
Century Therapeutics, Inc. (NASDAQ:IPSC) news
Every Century Therapeutics, Inc. press release and news update in one place — announcements, filings coverage, and company updates for investors.
Press releases & updates
Century Therapeutics Appoints Joseph Truitt to Board of Directors
September 9, 2026
Century Therapeutics Reports Second Quarter 2026 Financial Results and Business Updates
August 12, 2026
IHI Power Services Corp. Rebrands as Kyuden Energy Partners Following Acquisition by Japan's Kyuden Group
July 23, 2026
Century Therapeutics Selected for Oral Presentations of CNTY-813 Preclinical Data at EASD 2026 and Breakthrough T1D® Clinical & Research ...
July 9, 2026
New CNTY-813 Preclinical Data Demonstrate Durable Glucose Control, Immune Evasion Under Alloimmune Pressure, and Scalable Manufacturing a...
June 8, 2026
Century Therapeutics Reports First Quarter Financial Results and Business Updates
May 13, 2026
Century Therapeutics Selected for Oral Presentation of CNTY‑813 Preclinical Data at the American Diabetes Association 86th Scientific Ses...
April 30, 2026
Century Therapeutics Reports Full Year 2025 Financial Results and Business Updates
March 12, 2026
Century Therapeutics to Participate in Upcoming Investor Conferences in March
February 25, 2026
Century Therapeutics Secures Oversubscribed $135 Million Private Placement Financing to Support Lead Program, CNTY-813, a Potentially Cur...
January 8, 2026
Century Therapeutics : Initial Statement of Beneficial Ownership (Form 3)
December 11, 2025
Century Therapeutics Appoints Accomplished Biotechnology Leaders Dr. Han Lee and Dr. Martin Murphy to Board of Directors
December 9, 2025
Century Therapeutics to Participate in Piper Sandler 37th Annual Healthcare Conference
November 25, 2025
Century Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update
November 13, 2025
Century Therapeutics Announces New Beta Islet Program for Type 1 Diabetes
November 13, 2025
Century Therapeutics to Present at Chardan’s 9th Annual Genetic Medicines Conference
October 14, 2025
Century Therapeutics to Present at H.C. Wainwright 27th Annual Global Investment Conference
August 22, 2025
Century Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Update
August 14, 2025
Century Therapeutics Announces Two Upcoming Presentations at the EULAR 2025 Congress
May 28, 2025
Century Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update
May 15, 2025
Century Therapeutics Announces Two Upcoming Presentations at the ASGCT 28th Annual Meeting
April 28, 2025
Century Therapeutics to Host Live Fireside Chat Focused on Newly Prioritized Preclinical Cell Therapy Programs for Autoimmune Diseases an...
April 15, 2025
Century Therapeutics Reports Full Year 2024 Financial Results and Provides Business Update
March 19, 2025
Century Therapeutics Announces Investigator-Initiated Phase 1/2 Trial of its iPSC-derived iNK Cell Therapy CNTY-101 in B-cell Mediated Au...
January 21, 2025
Century Therapeutics to Present at the Piper Sandler 36th Annual Healthcare Conference
November 26, 2024
Century Therapeutics Announces Upcoming Poster Presentations at the 2024 American Society of Hematology (ASH) Annual Meeting
November 5, 2024
Century Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Updates
November 5, 2024
Century Therapeutics to Present at Guggenheim’s Inaugural Healthcare Innovation Conference
November 4, 2024
Century Therapeutics Strengthens Leadership Team with Appointments of Chief Financial Officer and Chief Scientific Officer
September 26, 2024
Century Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Updates
August 8, 2024
Century Therapeutics Presents Interim Results from Phase 1 ELiPSE-1 Study at ASCO 2024 Annual Meeting
June 3, 2024
Century Therapeutics Presents Preclinical Data Highlighting Advances in iPSC Platform Technology and Programs at 2024 ASGCT Annual Meeting
May 10, 2024
Century Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Updates
May 9, 2024
Century Therapeutics to Present at Chardan’s 8th Annual Genetic Medicines and Cell Therapy Manufacturing Summit
April 23, 2024
Century Therapeutics Strengthens Position in Autoimmune Disease with Strategic Pipeline Expansion Supported by $60 Million Private Placem...
April 11, 2024
Century Therapeutics Presents New Preclinical Data Highlighting iPSC-derived Cell Therapy Platform Technology at the 2024 American Associ...
April 8, 2024
Century Therapeutics to Present at the H.C. Wainwright 2nd Annual Cell Therapy Virtual Conference
March 19, 2024
Century Therapeutics Reports Full Year 2023 Financial Results and Provides Business Updates
March 14, 2024
Century Therapeutics Announces Six Upcoming Poster Presentations at the 2024 American Association for Cancer Research (AACR) Annual Meeting
March 5, 2024
Century Therapeutics to Present at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference
February 1, 2024
Century Therapeutics Presents Initial Data from CNTY-101 Phase 1 ELiPSE-1 Trial Supporting the Potential for a Multi-Dosing Strategy for ...
December 9, 2023
Century Therapeutics Receives FDA Clearance of IND Application for CNTY-101 in Systemic Lupus Erythematosus
December 6, 2023
Century Therapeutics to Host Conference Call to Discuss Preliminary Clinical Data from Phase 1 ELiPSE-1 trial of CNTY-101 in Relapsed or ...
December 6, 2023
Century Therapeutics to Present at the Piper Sandler 35th Annual Healthcare Conference
November 21, 2023
Century Therapeutics Appoints Brent Pfeiffenberger, Pharm.D., MBA, as Chief Executive Officer
November 9, 2023
Century Therapeutics and FUJIFILM Cellular Dynamics Announce Licenses for the Development and Commercialization of iPSC-Derived Cell Ther...
November 9, 2023
Century Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Updates
November 9, 2023
Century Therapeutics to Present Initial Clinical Data Supporting the Potential for a Multi-Dosing Strategy for CAR iNK Enabled by Allo-Ev...
November 2, 2023
Century Therapeutics to Present at the Chardan 7th Annual Genetic Medicines Conference
September 26, 2023
Century Therapeutics Reports Second Quarter 2023 Financial Results and Provides Business Updates
August 9, 2023